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Background: Pathological studies have revealed atherosclerotic changes within neointima (neoatherosclerosis) in the long-term process of arterial 
healing after stenting. However, in-vivo assessment of neoatherosclerosis development is still limited.
methods: A total of 197 stents (Paclitaxel-eluting stent: PES: n=63, Sirolimus-eluting stent: SES: n=98, Bare-metal stents: BMS: n=36) were 
evaluated by optical coherence tomography (OCT) >12months after stenting. In addition to the standard OCT evaluation, we performed a qualitative 
assessment for the presence of atherogenic neointima: neointima containing a diffuse border, signal-poor region with invisible struts underneath.
results: The average duration for long-term follow-up OCT was 33.0±13.8months for PES, 46.2±21.1 months for SES, and 39.2±27.5 months 
for BMS (P=0.58) after the index procedure. Although, the incidence of neoatherosclerosis was similar among the stent types (PES: 19.0% 
vs. SES: 15.3% vs. BMS: 16.7%), a significant difference in the timing of neoatherosclerosis development was noted; PES showed the earliest 
neoatherosclerosis progression, followed by SES and BMS (figure).
conclusions: The present long-term follow-up OCT study revealed that the incidence of neoatheroscrelosis was not different among PES, SES, 
and BMS almost 3 years after stenting. BMS showed, however, the latest progression of neoatherosclerosis than PES and SES, which seem to be 
consistent with previous pathological investigation.
